| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.726 | 0.006 | 0.726 | Aldehyde oxidase inhibitor | |||
| 0.696 | 0.003 | 0.696 | Peroxidase inhibitor | 0.111 0.11 CID_154699495 | ||
| 0.656 | 0.004 | 0.656 | GABA C receptor rho-3 antagonist | |||
| 0.629 | 0.004 | 0.629 | Lipid peroxidase inhibitor | 0.563 0.004 CID_154699495 | ||
| 0.599 | 0.006 | 0.599 | Calcium channel L-type activator | 0.41 0.074 CID_154699495 | ||
| 0.555 | 0.031 | 0.555 | 15-Lipoxygenase inhibitor | |||
| 0.513 | 0.019 | 0.714 | Antioxidant | 0.714 0.005 CID_154699495 | CID_154699495 | |
| 0.517 | 0.025 | 0.517 | 5 Hydroxytryptamine release stimulant | 0.31 0.067 CID_154699495 | ||
| 0.476 | 0.015 | 0.476 | Superoxide dismutase inhibitor | |||
| 0.461 | 0.005 | 0.461 | Cyclooxygenase 1 inhibitor | 0.241 0.023 CID_154699495 | ||
| 0.487 | 0.037 | 0.558 | 5 Hydroxytryptamine release inhibitor | 0.558 0.018 CID_154699495 | CID_154699495 | |
| 0.448 | 0.005 | 0.448 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.439 | 0.004 | 0.439 | Cystathionine beta-synthase inhibitor | 0.367 0.006 CID_154699495 | ||
| 0.442 | 0.012 | 0.442 | Anesthetic general | 0.42 0.014 CID_154699495 | ||
| 0.47 | 0.041 | 0.567 | Histamine release inhibitor | 0.567 0.014 CID_154699495 | CID_154699495 | |
| 0.439 | 0.013 | 0.439 | Calcium channel activator | 0.24 0.159 CID_154699495 | ||
| 0.422 | 0.016 | 0.422 | RNA-directed DNA polymerase inhibitor | 0.359 0.023 CID_154699495 | ||
| 0.474 | 0.071 | 0.474 | Caspase 9 stimulant | 0.452 0.082 CID_154699495 | ||
| 0.422 | 0.033 | 0.422 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.409 | 0.036 | 0.409 | Aryl hydrocarbon receptor agonist | |||
| 0.386 | 0.017 | 0.386 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.371 | 0.006 | 0.371 | GABA C receptor agonist | 0.095 0.073 CID_154699495 | ||
| 0.372 | 0.01 | 0.372 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.306 0.022 CID_154699495 | ||
| 0.366 | 0.005 | 0.366 | Carbonic anhydrase XV inhibitor | |||
| 0.449 | 0.096 | 0.705 | Alpha-glucosidase inhibitor | 0.705 0.033 CID_154699495 | CID_154699495 | |
| 0.357 | 0.008 | 0.367 | Neurotrophic factor enhancer | 0.367 0.008 CID_154699495 | CID_154699495 | |
| 0.38 | 0.034 | 0.493 | Interleukin 2 agonist | 0.493 0.009 CID_154699495 | CID_154699495 | |
| 0.353 | 0.014 | 0.353 | Phospholipase C inhibitor | 0.252 0.024 CID_154699495 | ||
| 0.399 | 0.064 | 0.707 | Transcription factor NF kappa B inhibitor | 0.707 0.02 CID_154699495 | CID_154699495 | |
| 0.377 | 0.043 | 0.377 | Lipoxygenase inhibitor | |||
| 0.384 | 0.053 | 0.656 | Cholesterol antagonist | 0.656 0.012 CID_154699495 | CID_154699495 | |
| 0.342 | 0.012 | 0.342 | Cyclooxygenase inhibitor | 0.208 0.039 CID_154699495 | ||
| 0.337 | 0.01 | 0.337 | Heat shock protein 90 alpha antagonist | |||
| 0.328 | 0.007 | 0.328 | Nitric-oxide synthase stimulant | 0.326 0.007 CID_154699495 | ||
| 0.369 | 0.049 | 0.369 | 12-Lipoxygenase inhibitor | |||
| 0.388 | 0.071 | 0.388 | Prostaglandin dehydrogenase inhibitor | |||
| 0.353 | 0.038 | 0.592 | Free radical scavenger | 0.592 0.009 CID_154699495 | CID_154699495 | |
| 0.323 | 0.015 | 0.649 | Amylase inhibitor | 0.649 0.004 CID_154699495 | CID_154699495 | |
| 0.338 | 0.032 | 0.338 | Sigma receptor agonist | |||
| 0.337 | 0.033 | 0.494 | Interleukin agonist | 0.494 0.009 CID_154699495 | CID_154699495 | |
| 0.332 | 0.034 | 0.492 | DNA synthesis inhibitor | 0.492 0.014 CID_154699495 | CID_154699495 | |
| 0.306 | 0.009 | 0.306 | Heat shock protein 90 antagonist | |||
| 0.302 | 0.006 | 0.302 | Histidine decarboxylase inhibitor | |||
| 0.333 | 0.039 | 0.333 | Pyruvate kinase inhibitor | |||
| 0.295 | 0.005 | 0.295 | Carbonic anhydrase III inhibitor | 0.171 0.022 CID_154699495 | ||
| 0.294 | 0.005 | 0.294 | Porphobilinogen synthase inhibitor | |||
| 0.288 | 0.005 | 0.288 | Alcohol oxidase inhibitor | |||
| 0.391 | 0.108 | 0.391 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.288 | 0.009 | 0.288 | Ferrochelatase inhibitor | |||
| 0.295 | 0.017 | 0.503 | Alpha-N-acetylglucosaminidase inhibitor | 0.503 0.005 CID_154699495 | CID_154699495 | |
| 0.281 | 0.007 | 0.281 | Carbonic anhydrase VI inhibitor | 0.12 0.029 CID_154699495 | ||
| 0.287 | 0.014 | 0.287 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.279 | 0.007 | 0.279 | GABA C receptor rho-2 antagonist | |||
| 0.274 | 0.005 | 0.274 | GABA C receptor antagonist | |||
| 0.273 | 0.004 | 0.273 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.312 | 0.052 | 0.312 | Insulysin inhibitor | |||
| 0.26 | 0.005 | 0.26 | Creatine kinase inhibitor | |||
| 0.255 | 0.004 | 0.255 | GABA aminotransferase inhibitor | 0.208 0.004 CID_154699495 | ||
| 0.259 | 0.01 | 0.273 | Mannose-6-phosphate isomerase inhibitor | 0.273 0.008 CID_154699495 | CID_154699495 | |
| 0.261 | 0.019 | 0.261 | Succinate dehydrogenase inhibitor | 0.145 0.123 CID_154699495 | ||
| 0.306 | 0.073 | 0.306 | Sodium/bile acid cotransporter inhibitor | 0.221 0.161 CID_154699495 | ||
| 0.24 | 0.008 | 0.24 | CF transmembrane conductance regulator agonist | 0.18 0.036 CID_154699495 | ||
| 0.256 | 0.027 | 0.425 | Interferon gamma antagonist | 0.425 0.009 CID_154699495 | CID_154699495 | |
| 0.306 | 0.083 | 0.49 | Vasodilator, coronary | 0.49 0.017 CID_154699495 | CID_154699495 | |
| 0.242 | 0.019 | 0.411 | Hexokinase inhibitor | 0.411 0.004 CID_154699495 | CID_154699495 | |
| 0.227 | 0.005 | 0.227 | GABA C receptor rho-1 antagonist | |||
| 0.252 | 0.03 | 0.252 | MAP kinase kinase 3 inhibitor | |||
| 0.249 | 0.027 | 0.427 | Protein kinase stimulant | 0.427 0.007 CID_154699495 | CID_154699495 | |
| 0.223 | 0.006 | 0.223 | Adenylate cyclase stimulant | 0.163 0.044 CID_154699495 | ||
| 0.24 | 0.023 | 0.24 | NADPH oxidase inhibitor | 0.167 0.045 CID_154699495 | ||
| 0.25 | 0.033 | 0.25 | Lipocortins synthesis antagonist | 0.203 0.054 CID_154699495 | ||
| 0.218 | 0.005 | 0.218 | DOPA decarboxylase inhibitor | |||
| 0.227 | 0.013 | 0.227 | Arachidonic acid antagonist | 0.178 0.055 CID_154699495 | ||
| 0.35 | 0.138 | 0.35 | DNA directed DNA polymerase inhibitor | |||
| 0.231 | 0.021 | 0.231 | Aldehyde dehydrogenase inhibitor | 0.19 0.03 CID_154699495 | ||
| 0.218 | 0.008 | 0.218 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.266 | 0.058 | 0.266 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.215 | 0.009 | 0.428 | NADH dehydrogenase inhibitor | 0.428 0.004 CID_154699495 | CID_154699495 | |
| 0.217 | 0.012 | 0.223 | Carbonic anhydrase XIII inhibitor | 0.223 0.011 CID_154699495 | CID_154699495 | |
| 0.23 | 0.028 | 0.307 | Interleukin 6 antagonist | 0.307 0.014 CID_154699495 | CID_154699495 | |
| 0.254 | 0.052 | 0.254 | MAP kinase kinase 2 inhibitor | |||
| 0.228 | 0.027 | 0.486 | Monophenol monooxygenase inhibitor | 0.486 0.008 CID_154699495 | CID_154699495 | |
| 0.245 | 0.049 | 0.334 | DNA methyltransferase I inhibitor | 0.334 0.017 CID_154699495 | CID_154699495 | |
| 0.36 | 0.165 | 0.798 | Antiinflammatory | 0.798 0.016 CID_154699495 | CID_154699495 | |
| 0.274 | 0.08 | 0.307 | Hypoxia-inducible factor 1 alpha inhibitor | 0.307 0.062 CID_154699495 | CID_154699495 | |
| 0.21 | 0.017 | 0.417 | UDP-glucose 4-epimerase inhibitor | 0.417 0.005 CID_154699495 | CID_154699495 | |
| 0.239 | 0.048 | 0.501 | Non-steroidal antiinflammatory agent | 0.501 0.007 CID_154699495 | CID_154699495 | |
| 0.203 | 0.013 | 0.203 | Estrogen antagonist | |||
| 0.21 | 0.019 | 0.21 | Toll-Like receptor 2 antagonist | |||
| 0.254 | 0.068 | 0.793 | Angiogenesis stimulant | 0.793 0.004 CID_154699495 | CID_154699495 | |
| 0.333 | 0.148 | 0.333 | DNA polymerase beta inhibitor | |||
| 0.214 | 0.029 | 0.214 | Anesthetic local | |||
| 0.193 | 0.01 | 0.193 | Estrogen receptor beta antagonist | |||
| 0.247 | 0.065 | 0.398 | Cyclic AMP phosphodiesterase inhibitor | 0.398 0.017 CID_154699495 | CID_154699495 | |
| 0.253 | 0.075 | 0.701 | Hypoglycemic | 0.701 0.005 CID_154699495 | CID_154699495 | |
| 0.253 | 0.076 | 0.253 | Gastrin inhibitor | 0.215 0.127 CID_154699495 | ||
| 0.282 | 0.106 | 0.282 | Vasodilator, peripheral | 0.261 0.119 CID_154699495 | ||
| 0.192 | 0.016 | 0.192 | Adenylate kinase inhibitor | 0.154 0.025 CID_154699495 | ||
| 0.183 | 0.008 | 0.183 | Glutamate decarboxylase inhibitor | |||
| 0.306 | 0.131 | 0.649 | Antibacterial | 0.649 0.013 CID_154699495 | CID_154699495 | |
| 0.181 | 0.007 | 0.181 | Ca2+-transporting ATPase inhibitor | 0.175 0.009 CID_154699495 | ||
| 0.236 | 0.064 | 0.245 | Psychostimulant | 0.245 0.06 CID_154699495 | CID_154699495 | |
| 0.204 | 0.033 | 0.204 | Neurotensin receptor agonist | |||
| 0.19 | 0.018 | 0.19 | 5 Hydroxytryptamine 3A agonist | |||
| 0.184 | 0.013 | 0.384 | Triose-phosphate isomerase inhibitor | 0.384 0.004 CID_154699495 | CID_154699495 | |
| 0.181 | 0.011 | 0.187 | Heat shock protein 70 antagonist | 0.187 0.009 CID_154699495 | CID_154699495 | |
| 0.276 | 0.106 | 0.698 | Antithrombotic | 0.698 0.008 CID_154699495 | CID_154699495 | |
| 0.206 | 0.038 | 0.358 | NOS3 expression enhancer | 0.358 0.011 CID_154699495 | CID_154699495 | |
| 0.188 | 0.021 | 0.188 | Nav1.1 sodium channel blocker | |||
| 0.215 | 0.049 | 0.215 | Histone acetyltransferase inhibitor | |||
| 0.204 | 0.039 | 0.371 | Melanin inhibitor | 0.371 0.014 CID_154699495 | CID_154699495 | |
| 0.218 | 0.055 | 0.218 | LIM domain kinase 1 inhibitor | |||
| 0.226 | 0.063 | 0.342 | DNA methylase inhibitor | 0.342 0.018 CID_154699495 | CID_154699495 | |
| 0.179 | 0.018 | 0.265 | Photosensitizer | 0.265 0.005 CID_154699495 | CID_154699495 | |
| 0.174 | 0.013 | 0.174 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.163 | 0.008 | 0.163 | Biliverdin reductase inhibitor | 0.115 0.015 CID_154699495 | ||
| 0.157 | 0.005 | 0.157 | H+/K+-transporting ATPase inhibitor | |||
| 0.171 | 0.019 | 0.171 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.248 | 0.097 | 0.532 | Immunostimulant | 0.532 0.025 CID_154699495 | CID_154699495 | |
| 0.171 | 0.019 | 0.171 | TRPA1 agonist | 0.107 0.076 CID_154699495 | ||
| 0.172 | 0.021 | 0.172 | Potassium channel (Ca-activated) activator | |||
| 0.154 | 0.005 | 0.154 | D-Ala-D-Ala ligase inhibitor | |||
| 0.176 | 0.027 | 0.176 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.17 | 0.021 | 0.17 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.223 | 0.074 | 0.42 | Peptidyltransferase inhibitor | 0.42 0.005 CID_154699495 | CID_154699495 | |
| 0.151 | 0.004 | 0.151 | Estrogen-related receptor beta agonist | |||
| 0.174 | 0.027 | 0.492 | Expectorant | 0.492 0.004 CID_154699495 | CID_154699495 | |
| 0.169 | 0.023 | 0.18 | Mucolytic | 0.18 0.019 CID_154699495 | CID_154699495 | |
| 0.163 | 0.017 | 0.163 | Prolactin inhibitor | |||
| 0.152 | 0.007 | 0.152 | NMDA 2C receptor antagonist | |||
| 0.202 | 0.06 | 0.202 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.197 | 0.055 | 0.197 | Tumour necrosis factor antagonist | |||
| 0.147 | 0.007 | 0.147 | Purinergic P2X1 antagonist | 0.08 0.025 CID_154699495 | ||
| 0.165 | 0.026 | 0.165 | Interleukin 8 antagonist | |||
| 0.157 | 0.018 | 0.157 | Alcohol dehydrogenase inhibitor | 0.122 0.033 CID_154699495 | ||
| 0.154 | 0.016 | 0.154 | Anabolic | 0.091 0.077 CID_154699495 | ||
| 0.18 | 0.042 | 0.185 | Alkaline phosphatase inhibitor | 0.185 0.04 CID_154699495 | CID_154699495 | |
| 0.171 | 0.035 | 0.171 | Interleukin 4 antagonist | 0.152 0.048 CID_154699495 | ||
| 0.204 | 0.068 | 0.204 | I kappa B kinase epsilon inhibitor | |||
| 0.186 | 0.05 | 0.314 | ATPase inhibitor | 0.314 0.005 CID_154699495 | CID_154699495 | |
| 0.136 | 0.002 | 0.136 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.019 CID_154699495 | ||
| 0.142 | 0.008 | 0.142 | Glycine receptor agonist | 0.124 0.011 CID_154699495 | ||
| 0.14 | 0.005 | 0.14 | Potassium channel (ATP-sensitive) blocker | |||
| 0.156 | 0.024 | 0.156 | Gastric antisecretory | |||
| 0.167 | 0.035 | 0.441 | Cyclooxygenase 3 inhibitor | 0.441 0.004 CID_154699495 | CID_154699495 | |
| 0.149 | 0.018 | 0.266 | Phosphofructokinase-1 inhibitor | 0.266 0.007 CID_154699495 | CID_154699495 | |
| 0.219 | 0.09 | 0.219 | Neuropeptide Y2 antagonist | |||
| 0.141 | 0.013 | 0.141 | Myeloperoxidase inhibitor | |||
| 0.147 | 0.02 | 0.147 | Electrolyte absorption antagonist | |||
| 0.136 | 0.01 | 0.136 | Carbonic anhydrase VB inhibitor | |||
| 0.142 | 0.016 | 0.142 | Keratolytic | |||
| 0.149 | 0.023 | 0.149 | Urease inhibitor | |||
| 0.14 | 0.016 | 0.147 | Interleukin 12 antagonist | 0.147 0.013 CID_154699495 | CID_154699495 | |
| 0.154 | 0.03 | 0.154 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.126 | 0.003 | 0.126 | Dopamine D5 agonist | |||
| 0.149 | 0.027 | 0.228 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.228 0.012 CID_154699495 | CID_154699495 | |
| 0.139 | 0.017 | 0.139 | Carbonic anhydrase V inhibitor | |||
| 0.162 | 0.041 | 0.162 | Nav1.6 sodium channel blocker | |||
| 0.131 | 0.01 | 0.131 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.126 | 0.006 | 0.126 | Heat shock protein 90 beta antagonist | |||
| 0.249 | 0.129 | 0.495 | Apoptosis antagonist | 0.495 0.021 CID_154699495 | CID_154699495 | |
| 0.125 | 0.006 | 0.125 | GABA B receptor agonist | |||
| 0.137 | 0.018 | 0.137 | Glutamate dehydrogenase inhibitor | 0.096 0.033 CID_154699495 | ||
| 0.161 | 0.042 | 0.161 | Farnesoid X receptor antagonist | |||
| 0.154 | 0.036 | 0.154 | Aminopeptidase B inhibitor | |||
| 0.21 | 0.093 | 0.297 | Antiamyloidogenic | 0.297 0.053 CID_154699495 | CID_154699495 | |
| 0.131 | 0.016 | 0.142 | Glutamate release inhibitor | 0.142 0.012 CID_154699495 | CID_154699495 | |
| 0.156 | 0.041 | 0.156 | Adenylate cyclase inhibitor | |||
| 0.166 | 0.051 | 0.344 | Cell wall synthesis inhibitor | 0.344 0.008 CID_154699495 | CID_154699495 | |
| 0.151 | 0.037 | 0.151 | Vanilloid 1 agonist | 0.139 0.052 CID_154699495 | ||
| 0.131 | 0.017 | 0.131 | Purinergic P2X2 antagonist | |||
| 0.152 | 0.039 | 0.176 | Beta amyloid protein antagonist | 0.176 0.026 CID_154699495 | CID_154699495 | |
| 0.179 | 0.066 | 0.179 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.117 | 0.005 | 0.117 | MAP kinase kinase 7 inhibitor | |||
| 0.164 | 0.053 | 0.489 | Hemostatic | 0.489 0.004 CID_154699495 | CID_154699495 | |
| 0.117 | 0.008 | 0.117 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.125 | 0.017 | 0.125 | Carbonic anhydrase VA inhibitor | |||
| 0.133 | 0.025 | 0.133 | MAP kinase kinase 1 inhibitor | |||
| 0.139 | 0.031 | 0.372 | Beta glucuronidase inhibitor | 0.372 0.004 CID_154699495 | CID_154699495 | |
| 0.13 | 0.023 | 0.13 | Histamine N-methyltransferase inhibitor | |||
| 0.156 | 0.05 | 0.156 | MAP kinase kinase 4 inhibitor | |||
| 0.121 | 0.015 | 0.121 | Carbamoyl phosphate synthetase inhibitor | 0.07 0.034 CID_154699495 | ||
| 0.287 | 0.182 | 0.583 | Apoptosis agonist | 0.583 0.053 CID_154699495 | CID_154699495 | |
| 0.145 | 0.04 | 0.197 | Microtubule formation inhibitor | 0.197 0.02 CID_154699495 | CID_154699495 | |
| 0.187 | 0.085 | 0.187 | Amyloid beta aggregation inhibitor | |||
| 0.148 | 0.047 | 0.148 | Cathepsin H inhibitor | |||
| 0.216 | 0.115 | 0.216 | Transcription factor STAT3 inhibitor | |||
| 0.124 | 0.023 | 0.124 | NMDA 2 receptor antagonist | |||
| 0.176 | 0.076 | 0.176 | Amyloid beta precursor protein antagonist | |||
| 0.112 | 0.012 | 0.133 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.133 0.01 CID_154699495 | CID_154699495 | |
| 0.124 | 0.024 | 0.124 | Macrophage migration inhibitory factor inhibitor | |||
| 0.176 | 0.076 | 0.176 | Dual specificity phosphatase 3 inhibitor | |||
| 0.187 | 0.088 | 0.187 | Insulin sensitizer | 0.182 0.093 CID_154699495 | ||
| 0.24 | 0.141 | 0.24 | Thioredoxin glutathione reductase inhibitor | |||
| 0.109 | 0.01 | 0.109 | Estrogen receptor beta agonist | |||
| 0.114 | 0.016 | 0.114 | Argininosuccinate synthase inhibitor | 0.078 0.026 CID_154699495 | ||
| 0.215 | 0.118 | 0.215 | Transcription factor STAT inhibitor | |||
| 0.111 | 0.013 | 0.111 | Maillard reaction inhibitor | 0.055 0.038 CID_154699495 | ||
| 0.116 | 0.019 | 0.116 | Aromatase inhibitor | |||
| 0.207 | 0.11 | 0.233 | DNA damaging | 0.233 0.091 CID_154699495 | CID_154699495 | |
| 0.139 | 0.043 | 0.266 | DNA repair enzyme inhibitor | 0.266 0.005 CID_154699495 | CID_154699495 | |
| 0.121 | 0.025 | 0.121 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.109 | 0.014 | 0.109 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.107 0.015 CID_154699495 | ||
| 0.144 | 0.049 | 0.282 | Alkylator | 0.282 0.014 CID_154699495 | CID_154699495 | |
| 0.192 | 0.098 | 0.192 | ErbB-1 antagonist | |||
| 0.124 | 0.03 | 0.124 | Protein kinase C zeta inhibitor | |||
| 0.101 | 0.006 | 0.101 | Transcription factor RelA inhibitor | |||
| 0.117 | 0.023 | 0.117 | Bile acid receptor antagonist | |||
| 0.098 | 0.005 | 0.098 | Dihydroorotate oxidase inhibitor | |||
| 0.207 | 0.114 | 0.313 | Spasmolytic | 0.313 0.065 CID_154699495 | CID_154699495 | |
| 0.166 | 0.074 | 0.166 | Death-associated protein kinase 2 inhibitor | |||
| 0.102 | 0.01 | 0.102 | Glutamate (mGluR6) antagonist | 0.07 0.039 CID_154699495 | ||
| 0.145 | 0.054 | 0.145 | MAP kinase kinase inhibitor | |||
| 0.158 | 0.067 | 0.158 | Acetylcholine M1 receptor antagonist | |||
| 0.152 | 0.06 | 0.152 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.105 | 0.014 | 0.105 | NMDA receptor glycine site agonist | |||
| 0.143 | 0.053 | 0.17 | DNA polymerase I inhibitor | 0.17 0.039 CID_154699495 | CID_154699495 | |
| 0.132 | 0.042 | 0.212 | Xanthine oxidase inhibitor | 0.212 0.017 CID_154699495 | CID_154699495 | |
| 0.106 | 0.017 | 0.106 | NMDA receptor agonist | |||
| 0.105 | 0.017 | 0.105 | CC chemokine 5 receptor agonist | |||
| 0.103 | 0.015 | 0.103 | Alpha tubulin antagonist | |||
| 0.096 | 0.011 | 0.096 | NMDA receptor subunit 3B antagonist | |||
| 0.15 | 0.065 | 0.15 | Neuropeptide Y1 antagonist | |||
| 0.094 | 0.01 | 0.094 | Topoisomerase II beta inhibitor | 0.064 0.019 CID_154699495 | ||
| 0.1 | 0.017 | 0.1 | Estrogen agonist | 0.043 0.04 CID_154699495 | ||
| 0.095 | 0.012 | 0.095 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.116 | 0.035 | 0.116 | Androgen antagonist | |||
| 0.097 | 0.016 | 0.097 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.178 | 0.097 | 0.178 | Interleukin antagonist | |||
| 0.128 | 0.047 | 0.128 | Transcription factor STAT6 inhibitor | |||
| 0.147 | 0.067 | 0.147 | Lck kinase inhibitor | |||
| 0.097 | 0.017 | 0.097 | Acyl-CoA dehydrogenase inhibitor | 0.051 0.041 CID_154699495 | ||
| 0.208 | 0.128 | 0.208 | Streptokinase A inhibitor | |||
| 0.103 | 0.024 | 0.103 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.085 | 0.006 | 0.085 | Adenylate cyclase 1 inhibitor | |||
| 0.089 | 0.01 | 0.089 | Estrogen receptor alpha agonist | |||
| 0.093 | 0.015 | 0.093 | Glutamate (mGluR7) antagonist | |||
| 0.174 | 0.097 | 0.174 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.113 | 0.036 | 0.148 | Thioredoxin inhibitor | 0.148 0.017 CID_154699495 | CID_154699495 | |
| 0.103 | 0.026 | 0.103 | Aminopeptidase I inhibitor | |||
| 0.086 | 0.01 | 0.086 | NMDA receptor subunit 3A antagonist | |||
| 0.108 | 0.032 | 0.108 | CYP2A6 inhibitor | |||
| 0.182 | 0.106 | 0.182 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.081 | 0.006 | 0.081 | Dihydropteroate synthase inhibitor | |||
| 0.159 | 0.085 | 0.159 | Dual specificity phosphatase inhibitor | |||
| 0.151 | 0.077 | 0.155 | Protein-tyrosine phosphatase inhibitor | 0.155 0.073 CID_154699495 | CID_154699495 | |
| 0.112 | 0.039 | 0.112 | NMDA receptor antagonist | |||
| 0.138 | 0.065 | 0.138 | Tubulin antagonist | |||
| 0.108 | 0.035 | 0.108 | Ornithine decarboxylase inhibitor | 0.086 0.06 CID_154699495 | ||
| 0.089 | 0.016 | 0.089 | NMDA 2A receptor antagonist | |||
| 0.102 | 0.03 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.123 0.014 CID_154699495 | CID_154699495 | |
| 0.233 | 0.161 | 0.233 | Calpain 2 inhibitor | |||
| 0.111 | 0.04 | 0.111 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.099 | 0.028 | 0.099 | Estrogen receptor alpha antagonist | |||
| 0.104 | 0.034 | 0.104 | Inducible nitric-oxide synthase inhibitor | |||
| 0.094 | 0.024 | 0.094 | Beta tubulin antagonist | |||
| 0.096 | 0.027 | 0.096 | HIV-1 integrase (3'-Processing) inhibitor | 0.057 0.051 CID_154699495 | ||
| 0.076 | 0.007 | 0.076 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.101 | 0.032 | 0.101 | mTOR complex 2 inhibitor | |||
| 0.078 | 0.01 | 0.078 | Ryanodine receptor antagonist | |||
| 0.071 | 0.005 | 0.071 | Glutamate (mGluR8) agonist | |||
| 0.119 | 0.053 | 0.119 | Protein kinase C gamma inhibitor | |||
| 0.156 | 0.09 | 0.432 | Nitric oxide antagonist | 0.432 0.022 CID_154699495 | CID_154699495 | |
| 0.086 | 0.021 | 0.086 | Androgen agonist | |||
| 0.072 | 0.006 | 0.072 | Dihydrofolate reductase inhibitor | |||
| 0.118 | 0.052 | 0.126 | Acetylcholine release stimulant | 0.126 0.04 CID_154699495 | CID_154699495 | |
| 0.118 | 0.054 | 0.118 | Nav1.4 sodium channel blocker | |||
| 0.11 | 0.046 | 0.11 | Nitric-oxide synthase inhibitor | |||
| 0.133 | 0.069 | 0.133 | Toll-Like receptor antagonist | |||
| 0.156 | 0.093 | 0.156 | Catenin beta inhibitor | |||
| 0.124 | 0.061 | 0.124 | Cholesterol synthesis inhibitor | |||
| 0.095 | 0.033 | 0.127 | Interferon agonist | 0.127 0.015 CID_154699495 | CID_154699495 | |
| 0.078 | 0.017 | 0.115 | Carbonic anhydrase XIV inhibitor | 0.115 0.008 CID_154699495 | CID_154699495 | |
| 0.092 | 0.033 | 0.124 | T cell inhibitor | 0.124 0.013 CID_154699495 | CID_154699495 | |
| 0.116 | 0.057 | 0.116 | Falcipain 3 inhibitor | |||
| 0.07 | 0.012 | 0.07 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.067 | 0.009 | 0.067 | Dopamine beta hydroxylase inhibitor | |||
| 0.08 | 0.023 | 0.08 | Alpha 2 adrenoreceptor agonist | |||
| 0.075 | 0.018 | 0.075 | Sphingosine kinase 2 inhibitor | |||
| 0.069 | 0.013 | 0.104 | Glucose-6-phosphate isomerase inhibitor | 0.104 0.004 CID_154699495 | CID_154699495 | |
| 0.137 | 0.081 | 0.137 | Pregnane X receptor agonist | |||
| 0.259 | 0.203 | 0.812 | Cyclophilin D inhibitor | 0.812 0.006 CID_154699495 | CID_154699495 | |
| 0.075 | 0.02 | 0.075 | Botulinum neurotoxin type A inhibitor | |||
| 0.106 | 0.05 | 0.106 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.095 | 0.04 | 0.095 | Adrenaline agonist | |||
| 0.14 | 0.085 | 0.14 | Phospholipase A2 inhibitor | 0.123 0.112 CID_154699495 | ||
| 0.11 | 0.055 | 0.18 | Toll-Like receptor 4 antagonist | 0.18 0.01 CID_154699495 | CID_154699495 | |
| 0.068 | 0.016 | 0.068 | Pregnane X receptor antagonist | |||
| 0.068 | 0.017 | 0.082 | Adenine nucleotide translocase inhibitor | 0.082 0.008 CID_154699495 | CID_154699495 | |
| 0.119 | 0.068 | 0.269 | Topoisomerase II inhibitor | 0.269 0.022 CID_154699495 | CID_154699495 | |
| 0.069 | 0.018 | 0.069 | Potassium channel (Inward rectifier) blocker | |||
| 0.077 | 0.026 | 0.101 | Interferon inducer | 0.101 0.012 CID_154699495 | CID_154699495 | |
| 0.07 | 0.019 | 0.07 | Aconitate hydratase inhibitor | |||
| 0.07 | 0.02 | 0.07 | Beta 2 adrenoreceptor agonist | |||
| 0.067 | 0.017 | 0.067 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.078 | 0.028 | 0.078 | Aryl hydrocarbon receptor antagonist | |||
| 0.059 | 0.011 | 0.059 | Alpha 1d adrenoreceptor agonist | |||
| 0.121 | 0.073 | 0.121 | Nav1.3 sodium channel blocker | |||
| 0.06 | 0.013 | 0.06 | Glutamate (mGluR group III) antagonist | |||
| 0.099 | 0.052 | 0.099 | Toll-Like receptor 3 antagonist | |||
| 0.071 | 0.025 | 0.071 | Calcium channel P-type blocker | |||
| 0.162 | 0.116 | 0.162 | Growth factor agonist | |||
| 0.051 | 0.005 | 0.051 | Glutamate (mGluR3) agonist | |||
| 0.059 | 0.014 | 0.059 | AICAR transformylase inhibitor | |||
| 0.048 | 0.004 | 0.048 | Estrogen-related receptor gamma antagonist | |||
| 0.121 | 0.077 | 0.121 | Acetylcholinesterase inhibitor | |||
| 0.073 | 0.029 | 0.073 | Carbonic anhydrase stimulant | |||
| 0.105 | 0.061 | 0.105 | MAO A inhibitor | |||
| 0.057 | 0.014 | 0.066 | Guanylate cyclase inhibitor | 0.066 0.007 CID_154699495 | CID_154699495 | |
| 0.096 | 0.053 | 0.096 | Potassium channel activator | |||
| 0.12 | 0.077 | 0.12 | M17 leucyl aminopeptidase inhibitor | |||
| 0.069 | 0.026 | 0.069 | Sphingosine kinase inhibitor | |||
| 0.073 | 0.03 | 0.073 | Beta 3 adrenoreceptor antagonist | |||
| 0.055 | 0.012 | 0.055 | Phosphoglycerate kinase inhibitor | |||
| 0.089 | 0.047 | 0.184 | Topoisomerase II alpha inhibitor | 0.184 0.017 CID_154699495 | CID_154699495 | |
| 0.103 | 0.061 | 0.103 | 5-Lipoxygenase inhibitor | |||
| 0.049 | 0.007 | 0.049 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.131 | 0.09 | 0.131 | Cytidine deaminase inhibitor | |||
| 0.071 | 0.03 | 0.071 | Xanthine dehydrogenase inhibitor | |||
| 0.073 | 0.033 | 0.073 | 5 Hydroxytryptamine 3 agonist | |||
| 0.056 | 0.017 | 0.056 | Geranyltranstransferase inhibitor | |||
| 0.131 | 0.093 | 0.294 | Diuretic | 0.294 0.023 CID_154699495 | CID_154699495 | |
| 0.16 | 0.122 | 0.16 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.107 | 0.069 | 0.107 | GABA receptor agonist | |||
| 0.072 | 0.035 | 0.072 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.059 | 0.022 | 0.059 | Adenosine deaminase inhibitor | 0.055 0.025 CID_154699495 | ||
| 0.062 | 0.025 | 0.145 | Alpha-mannosidase inhibitor | 0.145 0.004 CID_154699495 | CID_154699495 | |
| 0.042 | 0.005 | 0.042 | Glutamate (mGluR1a) agonist | |||
| 0.056 | 0.02 | 0.056 | Thymidylate synthase inhibitor | |||
| 0.06 | 0.024 | 0.06 | Immunoglobulin Fc receptor antagonist | |||
| 0.12 | 0.085 | 0.12 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.073 | 0.038 | 0.073 | Exportin-1 inhibitor | |||
| 0.039 | 0.004 | 0.063 | Vanilloid 2 agonist | 0.063 0.002 CID_154699495 | CID_154699495 | |
| 0.121 | 0.087 | 0.121 | Interleukin 1 antagonist | |||
| 0.055 | 0.021 | 0.055 | Oxytocin agonist | |||
| 0.137 | 0.103 | 0.137 | Mcl-1 antagonist | |||
| 0.043 | 0.009 | 0.043 | Estrogen-related receptor beta antagonist | |||
| 0.052 | 0.019 | 0.052 | Glutamate (mGluR4) antagonist | |||
| 0.084 | 0.051 | 0.134 | Glycine receptor antagonist | 0.134 0.012 CID_154699495 | CID_154699495 | |
| 0.118 | 0.086 | 0.118 | Nav1.2 sodium channel blocker | |||
| 0.073 | 0.041 | 0.073 | Potassium channel large-conductance Ca-activated activator | |||
| 0.06 | 0.028 | 0.06 | Epithelial sodium channel blocker | |||
| 0.104 | 0.073 | 0.104 | Protein kinase (CK2) alpha inhibitor | |||
| 0.139 | 0.108 | 0.139 | Antipruritic | |||
| 0.079 | 0.048 | 0.079 | Catalase inhibitor | |||
| 0.064 | 0.034 | 0.064 | Ribonucleotide reductase inhibitor | |||
| 0.045 | 0.015 | 0.045 | Fumarate hydratase inhibitor | 0.034 0.024 CID_154699495 | ||
| 0.072 | 0.043 | 0.072 | Protein kinase C beta inhibitor | |||
| 0.04 | 0.011 | 0.04 | Adenosine uptake inhibitor | 0.036 0.02 CID_154699495 | ||
| 0.062 | 0.033 | 0.062 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.047 | 0.018 | 0.047 | Kainate receptor agonist | |||
| 0.068 | 0.039 | 0.068 | 5 Hydroxytryptamine 2A agonist | |||
| 0.085 | 0.057 | 0.085 | Vanilloid agonist | |||
| 0.061 | 0.034 | 0.061 | Fatty acid synthase inhibitor | |||
| 0.044 | 0.017 | 0.044 | Glutamate (mGluR3) antagonist | |||
| 0.093 | 0.067 | 0.134 | Phosphodiesterase 6D inhibitor | 0.134 0.015 CID_154699495 | CID_154699495 | |
| 0.043 | 0.016 | 0.043 | Estrogen-related receptor alpha antagonist | |||
| 0.036 | 0.009 | 0.036 | Purinergic P2Y15 antagonist | |||
| 0.059 | 0.032 | 0.059 | Ornithine carbamoyltransferase inhibitor | |||
| 0.03 | 0.004 | 0.03 | Estrogen-related receptor gamma agonist | |||
| 0.098 | 0.072 | 0.219 | Mediator release inhibitor | 0.219 0.012 CID_154699495 | CID_154699495 | |
| 0.054 | 0.028 | 0.175 | Phosphorylase inhibitor | 0.175 0.006 CID_154699495 | CID_154699495 | |
| 0.068 | 0.042 | 0.068 | Beta adrenoreceptor antagonist | |||
| 0.045 | 0.02 | 0.045 | AMPA 4 receptor antagonist | |||
| 0.134 | 0.109 | 0.134 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.051 | 0.027 | 0.066 | Cytokine production stimulant | 0.066 0.009 CID_154699495 | CID_154699495 | |
| 0.091 | 0.067 | 0.091 | DNA directed RNA polymerase inhibitor | |||
| 0.084 | 0.06 | 0.084 | Bcr-Abl kinase inhibitor | |||
| 0.038 | 0.014 | 0.038 | ATP citrate lysase inhibitor | |||
| 0.155 | 0.131 | 0.155 | Dyrk kinase inhibitor | |||
| 0.048 | 0.025 | 0.048 | Glutamate (mGluR group III) agonist | |||
| 0.107 | 0.084 | 0.107 | MAO inhibitor | |||
| 0.054 | 0.031 | 0.054 | Vanilloid 2 antagonist | |||
| 0.197 | 0.174 | 0.277 | Caspase 3 stimulant | 0.277 0.092 CID_154699495 | CID_154699495 | |
| 0.033 | 0.01 | 0.033 | Thyroid hormone agonist | |||
| 0.06 | 0.038 | 0.06 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.062 | 0.039 | 0.062 | Cyclin D1 inhibitor | |||
| 0.03 | 0.008 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.1 | 0.077 | 0.1 | Chelator | |||
| 0.133 | 0.11 | 0.133 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.045 | 0.022 | 0.045 | Urate transporter 1 inhibitor | |||
| 0.049 | 0.027 | 0.155 | Mannosidase inhibitor | 0.155 0.004 CID_154699495 | CID_154699495 | |
| 0.07 | 0.049 | 0.07 | Secretase beta inhibitor | |||
| 0.086 | 0.064 | 0.086 | Bromodomain-containing protein 2 inhibitor | |||
| 0.053 | 0.032 | 0.053 | Beta 2 adrenoreceptor antagonist | |||
| 0.141 | 0.12 | 0.479 | Hepatoprotectant | 0.479 0.008 CID_154699495 | CID_154699495 | |
| 0.063 | 0.042 | 0.063 | Histone deacetylase SIRT3 inhibitor | |||
| 0.025 | 0.005 | 0.04 | Antibiotic Anthracycline-like | 0.04 0.002 CID_154699495 | CID_154699495 | |
| 0.062 | 0.042 | 0.062 | Heme oxygenase stimulant | |||
| 0.04 | 0.02 | 0.04 | Retinoid X alpha receptor agonist | |||
| 0.169 | 0.15 | 0.169 | Calpain inhibitor | |||
| 0.05 | 0.031 | 0.05 | Glycine transporter 2 inhibitor | |||
| 0.05 | 0.031 | 0.05 | AMPA receptor antagonist | |||
| 0.036 | 0.018 | 0.036 | Catechol O-methyltransferase inhibitor | |||
| 0.129 | 0.11 | 0.129 | MAP kinase 3 inhibitor | |||
| 0.048 | 0.03 | 0.048 | Carbonic anhydrase VII inhibitor | |||
| 0.115 | 0.097 | 0.115 | Histone deacetylase SIRT1 inhibitor | |||
| 0.05 | 0.033 | 0.05 | Squalene epoxidase inhibitor | |||
| 0.119 | 0.102 | 0.119 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.059 | 0.042 | 0.059 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.079 | 0.063 | 0.079 | Caspase 7 inhibitor | |||
| 0.117 | 0.1 | 0.117 | Activin receptor-like kinase 2 inhibitor | |||
| 0.039 | 0.023 | 0.072 | Arginase inhibitor | 0.072 0.007 CID_154699495 | CID_154699495 | |
| 0.032 | 0.016 | 0.049 | Uridine phosphorylase inhibitor | 0.049 0.009 CID_154699495 | CID_154699495 | |
| 0.043 | 0.027 | 0.043 | Kainate receptor antagonist | |||
| 0.043 | 0.028 | 0.043 | Heme oxygenase inhibitor | |||
| 0.148 | 0.132 | 0.148 | Anticonvulsant | |||
| 0.088 | 0.072 | 0.088 | Potassium channel (Voltage-sensitive) activator | |||
| 0.019 | 0.004 | 0.019 | Glutamate (mGluR6) agonist | |||
| 0.021 | 0.006 | 0.021 | NMDA receptor phencyclidine site antagonist | |||
| 0.027 | 0.013 | 0.027 | Glutamate (mGluR1) agonist | |||
| 0.038 | 0.024 | 0.038 | Retinoid X receptor agonist | |||
| 0.094 | 0.08 | 0.296 | AMP-activated protein kinase stimulant | 0.296 0.005 CID_154699495 | CID_154699495 | |
| 0.069 | 0.055 | 0.069 | Phospholipase D inhibitor | |||
| 0.022 | 0.008 | 0.022 | Alpha 2a adrenoreceptor agonist | |||
| 0.066 | 0.052 | 0.066 | MDM2 inhibitor | |||
| 0.021 | 0.008 | 0.021 | Nicotinic acid receptor 1 antagonist | |||
| 0.043 | 0.03 | 0.043 | GABA B receptor antagonist | |||
| 0.034 | 0.023 | 0.034 | Glutamate (mGluR4) agonist | |||
| 0.12 | 0.108 | 0.12 | Src kinase inhibitor | |||
| 0.077 | 0.066 | 0.077 | Glutathione S-transferase inhibitor | |||
| 0.019 | 0.008 | 0.027 | Telomerase stimulant | 0.027 0.004 CID_154699495 | CID_154699495 | |
| 0.045 | 0.034 | 0.045 | Beta adrenoreceptor agonist | |||
| 0.109 | 0.098 | 0.109 | Toll-Like receptor 9 antagonist | |||
| 0.04 | 0.029 | 0.04 | Thymidine kinase inhibitor | |||
| 0.069 | 0.059 | 0.069 | CDC25A inhibitor | |||
| 0.053 | 0.043 | 0.053 | Beta 1 adrenoreceptor antagonist | |||
| 0.024 | 0.014 | 0.031 | Dopamine D1 agonist | 0.031 0.008 CID_154699495 | CID_154699495 | |
| 0.026 | 0.016 | 0.026 | Complement factor 1s inhibitor | |||
| 0.061 | 0.051 | 0.121 | Neuraminidase (influenza) inhibitor | 0.121 0.012 CID_154699495 | CID_154699495 | |
| 0.079 | 0.07 | 0.079 | Opioid antagonist | |||
| 0.048 | 0.039 | 0.048 | CD45 antagonist | |||
| 0.028 | 0.019 | 0.028 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.034 | 0.026 | 0.034 | Opioid delta receptor agonist | |||
| 0.022 | 0.013 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.066 | 0.058 | 0.066 | Cathepsin G inhibitor | |||
| 0.026 | 0.018 | 0.109 | Sodium/glucose cotransporter 2 inhibitor | 0.109 0.003 CID_154699495 | CID_154699495 | |
| 0.077 | 0.07 | 0.077 | Thioredoxin reductase inhibitor | |||
| 0.041 | 0.033 | 0.041 | Nerve growth factor antagonist | |||
| 0.037 | 0.029 | 0.037 | Potassium channel Kv1.1 blocker | |||
| 0.145 | 0.138 | 0.145 | Focal adhesion kinase 2 inhibitor | |||
| 0.108 | 0.102 | 0.108 | Antibacterial (Helicobacter pylori) | |||
| 0.061 | 0.054 | 0.061 | Alpha adrenoreceptor agonist | |||
| 0.099 | 0.092 | 0.099 | Acetylcholine muscarinic antagonist | |||
| 0.047 | 0.041 | 0.047 | Sodium/calcium exchanger inhibitor | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.015 | 0.01 | 0.015 | CC chemokine 10 receptor antagonist | |||
| 0.05 | 0.045 | 0.05 | Lysine-specific demethylase 1A inhibitor | |||
| 0.054 | 0.048 | 0.054 | Leukotriene C antagonist | |||
| 0.027 | 0.021 | 0.027 | Hedgehog signaling activator | |||
| 0.01 | 0.005 | 0.01 | Progesterone receptor A antagonist | |||
| 0.05 | 0.045 | 0.05 | GABA receptor antagonist | |||
| 0.085 | 0.08 | 0.085 | Sphingomyelinase inhibitor | |||
| 0.03 | 0.025 | 0.03 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.039 | 0.034 | 0.039 | Sphingosine kinase 1 inhibitor | |||
| 0.023 | 0.019 | 0.023 | NMDA receptor glycine site antagonist | |||
| 0.038 | 0.034 | 0.038 | CF transmembrane conductance regulator antagonist | |||
| 0.008 | 0.004 | 0.008 | DNA topoisomerase III inhibitor | |||
| 0.018 | 0.014 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.018 | 0.015 | 0.018 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.091 | 0.088 | 0.133 | Protein-tyrosine phosphatase 1B inhibitor | 0.133 0.054 CID_154699495 | CID_154699495 | |
| 0.054 | 0.051 | 0.054 | Opioid delta receptor antagonist | |||
| 0.024 | 0.021 | 0.096 | Sodium/glucose cotransporter inhibitor | 0.096 0.003 CID_154699495 | CID_154699495 | |
| 0.031 | 0.028 | 0.031 | Purinergic P2Y2 antagonist | |||
| 0.025 | 0.022 | 0.025 | Thymidine phosphorylase inhibitor | |||
| 0.068 | 0.065 | 0.068 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.069 | 0.066 | 0.069 | Somatostatin 1 agonist | |||
| 0.069 | 0.067 | 0.069 | Vanilloid 4 agonist | |||
| 0.032 | 0.031 | 0.032 | Nicotinic acid receptor agonist | |||
| 0.045 | 0.044 | 0.045 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.141 | 0.139 | 0.141 | EphB2 antagonist | |||
| 0.024 | 0.023 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.089 | 0.088 | 0.089 | Glutamate (mGluR7) agonist | |||
| 0.06 | 0.059 | 0.06 | HIV-1 reverse transcriptase inhibitor | |||
| 0.082 | 0.081 | 0.082 | Protein kinase (CK2) inhibitor | |||
| 0.197 | 0.2 | 0.518 | Immunosuppressant | 0.518 0.028 CID_154699495 | CID_154699495 | |
| 0.012 | 0.02 | 0.036 | Ileal bile acid transport inhibitor | 0.036 0.004 CID_154699495 | CID_154699495 | |
| 0.007 | 0.017 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 CID_154699495 | CID_154699495 | |
| 0.044 | 0.057 | 0.056 | Factor III inhibitor | 0.056 0.022 CID_154699495 | CID_154699495 | |
| 0.045 | 0.06 | 0.151 | Heparanase inhibitor | 0.151 0.003 CID_154699495 | CID_154699495 | |
| 0.046 | 0.064 | 0.102 | Neuraminidase inhibitor | 0.102 0.015 CID_154699495 | CID_154699495 | |
| 0.01 | 0.028 | 0.015 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.015 0.011 CID_154699495 | CID_154699495 | |
| 0.022 | 0.042 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.014 CID_154699495 | CID_154699495 | |
| 0.043 | 0.063 | 0.058 | Leukotriene B4 antagonist | 0.058 0.031 CID_154699495 | CID_154699495 | |
| 0.084 | 0.106 | 0.096 | Folate antagonist | 0.096 0.072 CID_154699495 | CID_154699495 | |
| 0.052 | 0.081 | 0.23 | Antineoplastic antibiotic | 0.23 0.016 CID_154699495 | CID_154699495 | |
| 0.116 | 0.145 | 0.152 | CC chemokine 6 receptor antagonist | 0.152 0.02 CID_154699495 | CID_154699495 | |
| 0.071 | 0.101 | 0.233 | Topoisomerase I inhibitor | 0.233 0.019 CID_154699495 | CID_154699495 | |
| 0.015 | 0.046 | 0.068 | Protein 30S ribosomal subunit inhibitor | 0.068 0.005 CID_154699495 | CID_154699495 | |
| 0.026 | 0.057 | 0.087 | Antibiotic Aminoglycoside-like | 0.087 0.004 CID_154699495 | CID_154699495 | |
| 0.027 | 0.06 | 0.062 | Carbonic anhydrase XII inhibitor | 0.062 0.032 CID_154699495 | CID_154699495 | |
| 0.031 | 0.072 | 0.062 | Neuraminidase (Influenza A) inhibitor | 0.062 0.011 CID_154699495 | CID_154699495 | |
| 0.068 | 0.111 | 0.13 | ATPase (Vacuolar H+) inhibitor | 0.13 0.014 CID_154699495 | CID_154699495 | |
| 0.035 | 0.079 | 0.114 | Factor IXa inhibitor | 0.114 0.007 CID_154699495 | CID_154699495 | |
| 0.067 | 0.113 | 0.164 | Transcription factor NF kappa B stimulant | 0.164 0.013 CID_154699495 | CID_154699495 | |
| 0.035 | 0.097 | 0.097 | Glucose-6-phosphate translocase inhibitor | 0.097 0.006 CID_154699495 | CID_154699495 | |
| 0.023 | 0.092 | 0.064 | Aldose reductase inhibitor | 0.064 0.03 CID_154699495 | CID_154699495 | |
| 0.008 | 0.082 | 0.017 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.017 0.01 CID_154699495 | CID_154699495 | |
| 0.054 | 0.154 | 0.119 | Uric acid excretion stimulant | 0.119 0.038 CID_154699495 | CID_154699495 | |
| 0.002 | 0.104 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 CID_154699495 | CID_154699495 | |
| 0.041 | 0.154 | 0.067 | Lipocortins synthesis agonist | 0.067 0.025 CID_154699495 | CID_154699495 | |
| 0.023 | 0.137 | 0.05 | Microtubule stabilization | 0.05 0.028 CID_154699495 | CID_154699495 | |
| 0.021 | 0.139 | 0.118 | Protein 50S ribosomal subunit inhibitor | 0.118 0.01 CID_154699495 | CID_154699495 | |
| 0.024 | 0.144 | 0.389 | Selectin antagonist | 0.389 0.003 CID_154699495 | CID_154699495 | |
| 0.095 | 0.221 | 0.319 | Hypolipemic | 0.319 0.043 CID_154699495 | CID_154699495 | |
| 0.128 | 0.275 | 0.303 | Angiogenesis inhibitor | 0.303 0.091 CID_154699495 | CID_154699495 | |
| 0.045 | 0.194 | 0.133 | DNA intercalator | 0.133 0.051 CID_154699495 | CID_154699495 | |
| 0.044 | 0.209 | 0.181 | Cell adhesion molecule inhibitor | 0.181 0.011 CID_154699495 | CID_154699495 | |
| 0.062 | 0.231 | 0.325 | Cell adhesion inhibitor | 0.325 0.009 CID_154699495 | CID_154699495 | |
| 0.082 | 0.251 | 0.14 | P-glycoprotein inhibitor | 0.14 0.133 CID_154699495 | CID_154699495 | |
| 0.075 | 0.273 | 0.277 | Insulin secretagoues | 0.277 0.015 CID_154699495 | CID_154699495 | |
| 0.084 | 0.283 | 0.314 | Vasodilator | 0.314 0.044 CID_154699495 | CID_154699495 | |
| 0.07 | 0.28 | 0.404 | Platelet adhesion inhibitor | 0.404 0.011 CID_154699495 | CID_154699495 | |
| 0.028 | 0.245 | 0.079 | Histone deacetylase stimulant | 0.079 0.045 CID_154699495 | CID_154699495 | |
| 0.028 | 0.245 | 0.079 | Histone deacetylase SIRT1 stimulant | 0.079 0.045 CID_154699495 | CID_154699495 | |
| 0.043 | 0.262 | 0.099 | Multidrug resistance-associated protein 1 inhibitor | 0.099 0.08 CID_154699495 | CID_154699495 | |
| 0.041 | 0.275 | 0.325 | Thrombolytic | 0.325 0.02 CID_154699495 | CID_154699495 | |
| 0.039 | 0.276 | 0.085 | Falcipain 2 inhibitor | 0.085 0.064 CID_154699495 | CID_154699495 | |
| 0.039 | 0.28 | 0.087 | Falcipain inhibitor | 0.087 0.065 CID_154699495 | CID_154699495 | |
| 0.069 | 0.327 | 0.418 | Tumour necrosis factor alpha release inhibitor | 0.418 0.024 CID_154699495 | CID_154699495 | |
| 0.013 | 0.299 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 CID_154699495 | CID_154699495 | |
| 0.004 | 0.307 | 0.03 | Squalene synthetase inhibitor | 0.03 0.024 CID_154699495 | CID_154699495 | |
| 0.015 | 0.364 | 0.064 | Nitric oxide donor | 0.064 0.042 CID_154699495 | CID_154699495 | |
| 0.062 | 0.514 | 0.448 | Immunomodulator | 0.448 0.032 CID_154699495 | CID_154699495 | |
| 0.004 | 0.51 | 0.021 | Motilin receptor agonist | 0.021 0.018 CID_154699495 | CID_154699495 | |
| 0.014 | 0.616 | 0.227 | Anticoagulant | 0.227 0.044 CID_154699495 | CID_154699495 | |
| 0.017 | 0.619 | 0.269 | Platelet antagonist | 0.269 0.064 CID_154699495 | CID_154699495 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |